International Biotechnology (LON:IBT – Get Free Report) released its quarterly earnings data on Tuesday. The company reported GBX (10.22) earnings per share for the quarter, Digital Look Earnings reports. International Biotechnology had a net margin of 95.99% and a return on equity of 44.12%. The firm had revenue of GBX 46 million during the quarter.
International Biotechnology Trading Up 1.5%
LON IBT opened at GBX 1,060.63 on Thursday. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.32 and a current ratio of 0.11. The company has a market capitalization of £335.72 million, a price-to-earnings ratio of 4.39 and a beta of 0.47. The company’s 50-day simple moving average is GBX 1,077.95 and its two-hundred day simple moving average is GBX 1,010.51. International Biotechnology has a one year low of GBX 812 and a one year high of GBX 1,235.
About International Biotechnology
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.
Featured Stories
- Five stocks we like better than International Biotechnology
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
